Homepage
Policies & Regulations
New prescriptions for Humira®
January 3, 2025
Pharmacy

​​Effective January 1, 2025, Humira® (adalimumab) or adalimumab biosimilar will no longer be preferred on the AmeriHealth HMO, Inc. and AmeriHealth Insurance Company of New Jersey (collectively, AmeriHealth) Value, Select, and Premium Formularies. New prescriptions are now required for patients (our members) on Humira (adalimumab) or adalimumab biosimilars to access the preferred biosimilar indicated below.

Policies & Regulations
Coverage for certain drugs, biologics, and gene therapies with FDA-accelerated approval
January 17, 2025
Medical Policy
​AmeriHealth HMO, Inc. (AmeriHealth) covers drugs, biologics, and gene therapies that have received FDA-accelerated approval when research findings demonstrate direct evidence of their clinical effectiveness. Please note: The following benefit clarification does not apply to those members enrolled in AmeriHealth products in New Jersey.
Claims & Billing
New ID cards to be issued for members transitioning to the new platform on February 1, 2025 – be sure to use new ID numbers
February 3, 2025
Submitting Claims
We continue to transition members in group plans to our new operating platform each month upon their renewal date. Members will receive a new member ID card upon their transition.

Provider Services:

  • AmeriHealth New Jersey: 1-888-YOUR-AH1 (1-888-968-7241)
  • AmeriHealth Pennsylvania: 1-800-275-2583​
  • AmeriHealth Administrators: 1-800-841-5328​​​

​PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​



Filter to find the news that is relevant to your role.

Provider Services:

  • AmeriHealth New Jersey: 1-888-YOUR-AH1 (1-888-968-7241)
  • AmeriHealth Pennsylvania: 1-800-275-2583​
  • AmeriHealth Administrators: 1-800-841-5328​​​

​PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​



       
            Loading...